NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · IEX Real-Time Price · USD
1.130
-0.090 (-7.38%)
At close: May 17, 2024, 3:59 PM
1.140
+0.010 (0.88%)
After-hours: May 17, 2024, 7:56 PM EDT
Company Description
NewGenIVF Group Ltd. operates as an assisted reproductive services provider.
It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.
The company is headquartered in Bangkok, Thailand.
NewGenIvf Group Limited
| Country | Thailand |
| Founded | 2011 |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| CEO | Wing Fung Siu |
Contact Details
Address: 13/f, Ps Tower, Sukhumvit 21 Rd (Asoke) Bangkok, W1 0000 Thailand | |
| Phone | 852-2861-1666 |
Stock Details
| Ticker Symbol | NIVF |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| CIK Code | 0001981662 |
| ISIN Number | VGG0544E1051 |
| SIC Code | 8090 |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2024 | NT 20-F | Notification of inability to timely file Form 20-F |
| Apr 22, 2024 | 6-K | Report of foreign issuer |
| Apr 10, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Apr 10, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Apr 9, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Apr 4, 2024 | 6-K | Report of foreign issuer |
| Apr 3, 2024 | 8-K12B | Filing |
| Mar 1, 2024 | 424B3 | Prospectus |
| Feb 22, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 14, 2024 | EFFECT | Notice of Effectiveness |